Abstract Neutrophil to Lymphocyte Ratio (NLR) was recently demonstrated as a useful index
in predicting the prognosis of Non-Small Cell Lung Cancer (NSCLC). Thus, a meta-analysis …

Background Nivolumab improves the survival of advanced non-small cell lung cancer
(NSCLC), but a significant number of patients still fail to benefit from this treatment. In this …

Background: Lung cancer (LC) is still the primary cause of cancer deaths worldwide, and
late diagnosis is a major obstacle to improving lung cancer outcomes. Recently, elevated …

Background Metabolic information obtained through 18 F-flurodeoxyglucose positron
emission tomography/computed tomography (18 F-FDG PET/CT) is used to evaluate …

Haemogram assessment is a cheap and easy method which can be readily performed for
almost all patients. Leucocyte, neutrophil and lymphocyte counts and the neutrophil to …

Background The neutrophil to lymphocyte ratio (NLR) was recently shown to be a
remarkable prognostic factor in tumors. Moreover, some studies have indicated that the …

Background Neutrophil to lymphocyte ratio (NLR) has recently been reported to be a poor
prognostic indicator in lung cancer. However, the prognostic value of the NLR in patients …

The prognostic value of the platelet-to-lymphocyte ratio (PLR) in non-small cell lung cancer
(NSCLC) remains controversial. We therefore conducted a meta-analysis of published …

Background: Increasing amounts of evidence suggest patient-related systemic inflammatory
response (SIR) as a powerful prognostic factor in cancer and applicability of SIR as a …

Background: Colorectal cancers (CRC) are the third most common cancer in the western
world, with surgery preferred for management of non-metastatic disease and post surgical …